Milestone Scientific (MLSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -840 | -5,722 | -4,632 | -3,478 | -1,995 |
| Depreciation Amortization | 48 | 186 | 135 | 96 | 45 |
| Accounts receivable | 124 | -242 | -250 | -224 | -50 |
| Accounts payable and accrued liabilities | 472 | 1,275 | 1,526 | 441 | 1,165 |
| Other Working Capital | 563 | -94 | 449 | -385 | 317 |
| Other Operating Activity | -280 | 1,681 | 81 | 776 | -491 |
| Operating Cash Flow | $87 | $-2,917 | $-2,691 | $-2,772 | $-1,008 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -15 | -12 | -6 | -1 |
| Investing Cash Flow | $-2 | $-15 | $-12 | $-6 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 800 | 800 | 800 | N/A |
| Debt Repayment | -3 | -14 | -10 | -6 | -2 |
| Financing Cash Flow | $-3 | $786 | $790 | $794 | $-2 |
| Beginning Cash Position | 1,113 | 3,258 | 3,258 | 3,258 | 3,258 |
| End Cash Position | 1,194 | 1,113 | 1,345 | 1,274 | 2,246 |
| Net Cash Flow | $82 | $-2,145 | $-1,913 | $-1,984 | $-1,012 |
| Free Cash Flow | |||||
| Operating Cash Flow | 87 | -2,917 | -2,691 | -2,772 | -1,008 |
| Capital Expenditure | -2 | -15 | -12 | -6 | -1 |
| Free Cash Flow | 85 | -2,932 | -2,703 | -2,778 | -1,009 |